These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 657405)

  • 41. Synthesis and antianxiety activity of (omega-piperazinylalkoxy)indan derivatives.
    Kikumoto R; Tobe A; Fukami H; Egawa M
    J Med Chem; 1983 Feb; 26(2):246-50. PubMed ID: 6131132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of the estrogenic activity of stilbestrol by spiro (cyclohexane-1,2'-indan)-1',4-dione.
    Bailey DJ; Doggett NS; Ng LY; Qazi T
    J Med Chem; 1976 Mar; 19(3):438-9. PubMed ID: 1255671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomimetic synthesis of cannabispiran.
    El-Feraly FS; Chan YM; El-Sohly MA; Turner CE
    Experientia; 1979 Sep; 35(9):1131-2. PubMed ID: 488253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoquaternary neuromuscular blocking agents based on 1-tetralone and 1-indanone.
    Biggs DF; Casy AF; Chu I; Coutts RT
    J Med Chem; 1976 Apr; 19(4):472-5. PubMed ID: 1263199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [1,3-Dicarbonyl compounds, 5. Enolacetates of 2-acyl-1-indanones].
    Görlitzer K
    Arch Pharm (Weinheim); 1975 May; 308(5):394-7. PubMed ID: 1164169
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.
    Saito S; Matsui S; Fukushima S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1989 Dec; 39(12):1558-61. PubMed ID: 2560371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Formation of hydrindane derivatives by rearrangement of nardofurane (author's transl)].
    Rücker G; Hembeck HW
    Arch Pharm (Weinheim); 1978 Jun; 311(6):511-5. PubMed ID: 678056
    [No Abstract]   [Full Text] [Related]  

  • 48. Potential antiinflammatory agents. V. Synthesis of metabolites of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284) using microbiological hydroxylation.
    Kishimoto S; Sugino H; Tanaka K; Kakinuma A; Noguchi S
    Chem Pharm Bull (Tokyo); 1976 Apr; 24(4):584-90. PubMed ID: 1084790
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on tenuazonic acid analogs. V. Syntheses and antitumor activities of indane-1, 3-dione derivatives (author's transl)].
    Matsuo T; Takagi T; Saito K; Yuki H; Yamaguchi T
    Yakugaku Zasshi; 1981 Oct; 101(10):960-4. PubMed ID: 7338794
    [No Abstract]   [Full Text] [Related]  

  • 50. [Thioamide derivatives of 1,2,3-trioxoindane (author's transl)].
    Matthies D; Hain K
    Arch Pharm (Weinheim); 1977 Dec; 310(12):1001-4. PubMed ID: 610674
    [No Abstract]   [Full Text] [Related]  

  • 51. [Research on substances with antiviral activities. IV. Position of the lateral chain and activity of hydrazonic derivatives of benzindanones and naphthofuranones].
    Cavrini V; Giovanninetti G; Chiarini A; Palenzona A; Borgatti M
    Farmaco Sci; 1975 Dec; 30(12):974-82. PubMed ID: 1204835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754.
    Carter PH
    Expert Opin Ther Pat; 2010 Feb; 20(2):283-9. PubMed ID: 20100008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic disposition of 6-chloro-5-cyclohexyl-1-indancarboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent, in rhesus monkeys.
    Tanayama S; Kanai Y
    Xenobiotica; 1977 Mar; 7(3):145-51. PubMed ID: 403686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enantioselective synthesis of substituted indanones from silyloxyallenes.
    Brekan JA; Reynolds TE; Scheidt KA
    J Am Chem Soc; 2010 Feb; 132(5):1472-3. PubMed ID: 20085317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Modification of amino acids and peptides. 8. Modification of amino acids and peptides with a 2-((alpha-amino)-p-nitrobenzylidene)-1,3-indandione residue].
    Nacev I; Aleksiev B; Milosev M
    Pharmazie; 1978 Apr; 33(4):192-6. PubMed ID: 674312
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of anti-inflammatory 2-aryl-1,3-indandiones on oxidative phosphorylation in rat liver mitochondria.
    Van Den Berg G; Nauta WT
    Biochem Pharmacol; 1975 Apr; 24(7):815-21. PubMed ID: 123746
    [No Abstract]   [Full Text] [Related]  

  • 57. N-Substituted indanamines as potential hypoglycemic agents.
    Lahiri S; Gupta JK; Mondal AK
    J Pharm Sci; 1975 Jan; 64(1):172-4. PubMed ID: 1133698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers.
    Kawai K; Shiojiri H; Fukushima H; Nozawa Y; Hasegawa J; Nozaki M; Tsurumi K; Fujimura H
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):399-406. PubMed ID: 6334337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a new anti-inflammatory compound, CGP 28237, on arachidonate metabolism in rat gastrointestinal tissue.
    Green JR; Böttcher I; Peskar BA
    Agents Actions; 1988 Feb; 23(1-2):110-1. PubMed ID: 3354373
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies on anti-inflammatory, analgesic and antipyretic activities of some indan acids.
    Roy A; Gupta JK; Lahiri SC
    Indian J Physiol Pharmacol; 1980; 24(4):310-6. PubMed ID: 6971256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.